Literature DB >> 83110

Trypanosoma cruzi-sensitized T-lymphocyte mediated 51CR release from human heart cells in Chagas' disease.

A R Teixeira, G Teixeira, V Macêdo, A Prata.   

Abstract

Cytotoxicity of T-lymphocytes from patients with Chagas' disease to parasitized and non-parasitized human heart cells labelled with 51Cr was demonstrated. The highest ratio of 51Cr released from the normal, non-parasitized heart cells was observed when the T-lymphocytes were collected from patients with acute Chagas' disease. The quantity of 51Cr released from the normal heart cells that were destroyed by T-lymphocytes collected from patients with chronic Chagas' disease was also significantly higher than the quantity of 51Cr released from normal heart cells incubated with lymphocytes from normal donors. The specific release of 51Cr from the heart cell cultures destroyed by the immune T-lymphocytes from patients with acute Chagas' disease and from patients with chronic disease was 38.1% and 25.8%, respectively, compared to the release of 51Cr observed in control studies. A small particle human heart cell antigen was shown to inhibit the migration of Trypanosoma cruzi-immune peripheral blood leukocytes. The findings appear to indicate that T-lymphocytes from patients with Chagas' disease are susceptible to activation by a cross-reactive heart cell antigen and suggest that an autoimmune mechanism can be established in some cases of acute Chagas' disease and can be perpetuated in the chronic phase of this disease by the continuous antigenic stimulation. Further, these experimental data indicate that the autoimmune destruction of heart cells in Chagas' disease is produced by delayed-type hypersensitivity mediated by T. cruzi-sensitized T-lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 83110     DOI: 10.4269/ajtmh.1978.27.1097

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  18 in total

1.  Chagas' disease in inbred III/J rabbits.

Authors:  A R Teixeira
Journal:  Am J Pathol       Date:  1986-08       Impact factor: 4.307

2.  Autoimmunity in Chagas' disease: specific inhibition of reactivity of CD4+ T cells against myosin in mice chronically infected with Trypanosoma cruzi.

Authors:  L V Rizzo; E Cunha-Neto; A R Teixeira
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

3.  Immunopathology of experimental Chagas' disease: binding of T cells to Trypanosoma cruzi-infected heart tissue.

Authors:  R C Mortatti; L C Maia; A V de Oliveira; M E Munk
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

4.  Delayed hypersensitivity to heart antigens in Chagas' disease as measured by in vitro lymphocyte stimulation.

Authors:  W Mosca; J Plaja
Journal:  J Clin Microbiol       Date:  1981-07       Impact factor: 5.948

5.  Intensification of acute Trypanosoma cruzi myocarditis in BALB/c mice pretreated with low doses of cyclophosphamide or gamma irradiation.

Authors:  J S Silva; M A Rossi
Journal:  J Exp Pathol (Oxford)       Date:  1990-02

6.  Adoptive transfer of protection against Trypanosoma cruzi with lymphocytes and macrophages.

Authors:  D E Burgess; W L Hanson
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

Review 7.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

8.  Modulation of autoimmunity by treatment of an infectious disease.

Authors:  Kenneth V Hyland; Juan S Leon; Melvin D Daniels; Nick Giafis; LaKitta M Woods; Thomas J Bahk; Kegiang Wang; David M Engman
Journal:  Infect Immun       Date:  2007-05-07       Impact factor: 3.441

Review 9.  Chagas' disease.

Authors:  H B Tanowitz; L V Kirchhoff; D Simon; S A Morris; L M Weiss; M Wittner
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

10.  Suppressor T lymphocyte function in patients with idiopathic congestive cardiomyopathy.

Authors:  P J Lowry; M D Gammage; T A Gentle; M I Baynham; R A Thompson; W A Littler
Journal:  Br Heart J       Date:  1987-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.